The latest from BioStock
» Alligator Bioscience receives orphan drug designation for mitazalimab
» Carbiotix CEO updates on the latest news
Read BioStock's newsletter for v.20 here.
It's happening soon!
Morning news
BioInvent and Transgene. reports positive phase Ia data for oncolytic virus BT 001 in solid tumors. Read more.
Mendus participating in several conferences in June 2023. Read more.
Targovax is now called Circio and is traded under the ticker symbol CRNA. Read more.
A study from Manchester University Hospital shows strong long-term data with Bone supports CERAMENT G in severe open fractures. Read more.
AstraZeneca will present a broad range of the company's oncology portfolio and pipeline at ASCO 2023. Read more.
Stenocares AD 10-10 STENOCARE Extract receives approval for sale in Germany. Read more.
Inhalation Sciences receives 125 euros in funding for a pan-European research project on antibiotic resistance and inhaled antibiotics. Read more.
PharmNovo strengthens the team with Jesper Kjerulff as project manager/COO. Read more.
BergenBio will present two abstracts at ASCO 2023. Read more.
A Capital Markets Day is being held today, May 25th, by Orion. Read more.
Elekta publishes year-end report for 2022/2023. Read more.
Paxman has been interviewed by Redeye about the Q1 report. Read more.
Watch the latest episode of The IPO round in the banner below!
Interim reports:
Chordate Medical Clinical Laserthermia Systems Coegin Pharma Curasight Dignity Genetic Analysis Lipigon Nanoform Promimic Ray Intelligence Saniona Scandinavian ChemoTech SelectImmune Pharma Vivesto Xintela 2cureX
Communiqués:
Active Biotech Annexin Pharmaceuticals AroCell Double Bond Pharmaceutical ExpreS2ion Biotech InDex Pharmaceuticals Paxman Pharmiva Vivesto Ziccum
Invitations:
Insider trading:
News since Wednesday lunch
AlzeCure has announced positive data from a Phase IIa clinical trial in neuropathic pain with the non-opioid ACD440. Read more.
Xintela is carrying out a rights issue of units of approximately SEK 123 million. Read more.
Alligator has published another supplementary prospectus regarding the invitation to subscribe for units. Read more.
CombiGene has released a new issue of the newsletter Geneva Road. Read more.
Bioservo has published a prospectus regarding the rights issue. Read more.
EQL Pharma has entered into a strategic licensing agreement with Adalvo - for Mellozza outside Europe. Read more.
Orthoma initiates market launch in Japan and the company receives 2 million USD for exclusive distribution rights of OTS Hip. Read more.
Novo Nordisk and Life Edit Therapeutics establishes collaboration to discover and develop gene therapies for rare and cardiometabolic diseases. Read more.
RaySearch Laboratories has announced that the oncology information system RayCare can be connected to Varian linear accelerators TrueBeam. Read more.
Calmark has received notification of approved patent in China. Read more.
Alvotech and Advanz Pharma expands strategic partnership to commercialize five biosimilars in Europe. Read more.
Nasdaq delisting decision does not affect agreements entered into regarding financing for ISR Holding, the company announced. Read more.
Magle Group has applied for extended European patent protection for its DSM technology. Read more.
ApoEx has informed about the new business area ApoEx Tech. Read more.
SpectraCure has changed news distributor. Read more.
Voting rights for PCI Biotechs Chairman of the Board has been announced. Read more.
This morning's price development
Winner: Abera Bioscience 18,7%, Active Biotech 18,4%, Gabather 15,3%, 2cureX 13,7%, Dignitana 12,1%
Förlorare: Raytelligence -14,1%, Amniotics -13,9%, Scandinavian ChemoTech -9,1%, RLS Global -8,5%, Klaria Pharma -7,0%
Index: OMXS30 2223 -0,27%, Healthcare 0,51%